Exo-Selective Asymmetric Inverse-Electron Demand Hetero-Diels-Alder Reaction Catalyzed by Cu(II)-Hydroxy Oxazoline Ligands

Abstract

Cu(II) complexes of hydroxy oxazolines derived from (+)-(S)-ketopinic acid catalyze the asymmetric hetero-Diels-Alder cycloaddition of enol ethers and β,γ-unsaturated α-keto esters. The reaction takes place with unprecedented exo selectivity providing 2,4-trans-disubstituted chiral 2,3-dihydropyrans with up to 88% ee.

asymmetric catalysis - cycloaddition - copper - acetals - heterocycles

References and Notes

1 Gunatilaka AAL. J. Nat. Prod.  2006,  69:  509 

For reviews, see:

2a Yeung K.-S. Paterson I. Chem. Rev.  2005,  105:  4237 

2b Kang EJ. Lee E. Chem. Rev.  2005,  105:  4348 

2c Inoue M. Chem. Rev.  2005,  105:  4379 

2d Aho JE. Pihko PM. Rissa TK. Chem. Rev.  2005,  105:  4406 

2e Nakata T. Chem. Rev.  2005,  105:  4314 

2f Goldring WPD. Pattenden G. Acc. Chem. Res.  2006,  39:  354 

2g Yet L. Chem. Rev.  2003,  103:  4283 

2h . Nasreen A. Akhtar F. Shekhani MS. Clardy J. Parvez M. Choudhary MI. J. Nat. Prod.  1997,  60:  472 

2i Brimble MA. Prabaharan H. Tetrahedron  1998,  54:  2113 

2j Conway JC. Quayle P. Regan AC. Urch CJ. Tetrahedron  2005,  61:  11910 

2k Tang Y. Oppenheimer J. Song Z. You L. Zhang X. Hsung RP. Tetrahedron  2006,  62:  10785 

2l Goddard-Boger ED. Ghisalberti EL. Stick RV. Eur. J. Org. Chem.  2007,  3925 

2m Kumar S. Malachowski WP. DuHadaway JB. LaLonde JM. Carroll PJ. Jaller D. Metz R. Prendergast GC. Muller AJ. J. Med. Chem.  2008,  51:  1706 

2n Yoo NH. Jang DS. Yoo JL. Lee YM. Kim YS. Cho J.-H. Kim JS. J. Nat. Prod.  2008,  71:  713 

3 Tietze LF. Kettschau G. Top. Curr. Chem.  1997,  189:  12120 

4a Jørgensen KA. in Cycloaddition Reactions in Organic Synthesis   Kobayashi S. Jørgensen KA. Wiley; New York: 2002. 

4b Jørgensen KA. Eur. J. Org. Chem.  2004,  2093 

4c Lin L. Liu X. Feng X. Synlett  2007,  2147 

5a Tietze LF. Saling P. Synlett  1992,  281 

5b Tietze LF. Saling P. Chirality  1993,  5:  329 

6a Wada E. Yasuoka H. Kanemasa S. Chem. Lett.  1994,  23:  1637 

6b Wada E. Pei W. Yasuoka H. Chin U. Kanemasa S. Tetrahedron  1996,  52:  1205 

7a Evans DA. Johnson JS. J. Am. Chem. Soc.  1998,  120:  4895 

7b Evans DA. Olhava EJ. Johnson JS. Angew. Chem. Int. Ed.  1998,  37:  3372 

7c Evans DA. Johnson JS. Burgy CS. Campos KR. Tetrahedron Lett.  1999,  40:  2879 

7d Evans DA. Johnson JS. Olhava EJ. J. Am. Chem. Soc.  2000,  122:  1635 

8a Thorhauge J. Johannsen M. Jørgensen KA. Angew. Chem. Int. Ed.  1998,  37:  2404 

8b Audrian H. Thorhauge J. Hazell RG. Jørgensen KA. J. Org. Chem.  2000,  65:  4487 

8c Zhuang W. Thorhauge J. Jørgensen KA. Chem. Commun.  2000,  459 

8d Audrian H. Jørgensen KA. J. Am. Chem. Soc.  2000,  122:  11543 

The HDA reaction has also been carried out with immobilized BOX ligands, see:

9a Shin YJ. Yeom C.-E. Kim MJ. Kim BM. Synlett  2008,  89 

9b O’Leary P. Krosveld NP. De Jong KP. van Koten G. Klein Gebbink RJM. Tetrahedron Lett.  2004,  45:  3177 

9c Wan Y. McMorn P. Hancock FE. Hutchings GJ. Catal. Lett.  2003,  91:  145 

9d Kurosu M. Porter JR. Foley MA. Tetrahedron Lett.  2004,  45:  145 

10 Barroso S. Blay G. Muñoz MC. Pedro JR. Adv. Synth. Catal.  2009,  351:  107 

11 Selective endo or exo approach in the HDA reaction between vinyl ethers and a,b-unsaturated acyl esters, has been accomplished by using Eu or Sn Lewis acids, in a non-asymmetric reaction, see: Martel A. Leconte S. Dujardin G. Brown E. Maisonneuve V. Retoux R. Eur. J. Org. Chem.  2002,  514 

12 Barroso S. Blay G. Cardona L. Pedro JR. Synlett  2007,  2659 

13a Barroso S. Blay G. Pedro JR. Org. Lett.  2007,  9:  1983 

13b Barroso S. Blay G. Al-Midfa L. Muñoz MC. Pedro JR. J. Org. Chem.  2008,  73:  6389 

13c Barroso S. Blay G. Muñoz MC. Pedro JR. Org. Lett.  2011,  13:  402 

14 Sakakura A. Kondo R. Ishihara K. Org. Lett.  2005,  7:  1971 

15 Yamada K. Maekawa M. Akindele T. Nakano M. Yamamoto Y. Tomioka K. J. Org. Chem.  2008,  73:  9535 

16

We have not determined the absolute stereochemistry of the minor endo-adducts 10. For a description of these adducts see refs. 5 and 6.

17

Synthesis of Ligand 5: A solution of (S)-(+)-ketopinic acid (1; 1.0 g, 5.5 mmol) in SOCl₂ (4.5 mL) was refluxed for 2 h and the excess SOCl₂ was removed under reduced pressure. The residue dissolved in CH₂Cl₂ (3.8 mL) was added drop-wise to a solution of (R)-2-amino-2-phenylethanol (0.76 g, 5.5 mmol) and Et₃N (0.75 mL, 5.5 mmol) in CH₂Cl₂ (3 mL) at 0 ˚C under nitrogen. After 1 h, the mixture was diluted with EtOAc (150 mL), washed with 2 M HCl (2 × 30 mL), sat. aq NaHCO₃ (2 × 30 mL) and brine (30 mL), dried
over MgSO₄ and concentrated. The crude product was crystallized from hexane-CH₂Cl₂ to give 1.49 g (90%) of hydroxy amide; mp 140-142 ˚C; [α]_D ^²5 -6.2 (c = 0.78, CHCl₃). ^¹H NMR (300 MHz, CDCl₃): δ = 8.37 (d, J = 6.4 Hz, 1 H), 7.32 (m, 5 H), 5.15 (td, J = 5.4, 7.0 Hz, 1 H), 3.87 (m, 2 H), 2.81 (s, 1 H), 2.58 (m, 1 H), 2.51 (dd, J = 4.7, 8.5 Hz, 1 H), 2.17 (m, 1 H), 2.09 (t, J = 4.4 Hz, 1 H), 2.00 (d, J = 18.8 Hz, 1 H), 1.69 (ddd, J = 4.6, 9.2, 13.8 Hz, 1 H), 1.45 (m, 1 H), 1.22 (s, 3 H), 0.94 (s, 3 H). ^¹³C NMR (75.5 MHz, CDCl₃): δ = 217.3 (s), 169.8 (s), 139.0 (s), 128.7 (d), 127.6 (d), 126.5 (d), 67.1 (t), 64.5 (s), 55.7 (d), 50.3 (s), 43.6 (t), 43.2 (d), 28.4 (t), 27.7 (t), 20.8 (q), 20.3 (q). MS (FAB):
m/z (%) = 302 (100) [M⁺ + 1], 154 (71), 137 (58). HRMS: m/z calcd for C₁₈H₂₄NO₃: 302.1756; found: 302.1754.
Mesyl chloride (6.75 mmol) was added dropwise to a solution of hydroxy amide (1.03 g, 3.4 mmol), Et₃N (5.8 mL) and diisopropylethylamine (1.2 mL) in CH₂Cl₂ (17 mL) under nitrogen at 0 ˚C. The reaction was stirred overnight. After this time, the reaction mixture was diluted with EtOAc (200 mL), washed with H₂O (2 × 25 mL) and brine (25 mL), dried over MgSO₄, concentrated under reduced pressure and the product was purified by flash chromatography eluting with hexane-EtOAc to give 0.93 g (96%) of keto-oxazoline; mp 122-125 ˚C; [α]_D ^²5 +88.5 (c = 0.73, CHCl₃). ^¹H NMR (300 MHz, CDCl₃): δ = 7.29 (m, 5 H), 5.23 (dd, J = 8.0, 10.2 Hz, 1 H), 4.67 (dd, J = 8.5, 10.1 Hz, 1 H), 4.07 (t, J = 8.1 Hz, 1 H), 2.49-2.64 (m, 2 H), 2.16 (t, J = 4.4 Hz, 1 H), 2.07 (m, 1 H), 1.98 (d, J = 18.3 Hz, 1 H), 1.84 (ddd, J = 4.7, 9.2, 13.9 Hz, 1 H), 1.43 (ddd, J = 4.0, 9.2, 12.9 Hz, 1 H), 1.19 (s, 3 H), 1.13 (s, 3 H). ^¹³C NMR (75.5 MHz, CDCl₃): δ = 211.9 (s), 165.4 (s), 142.4 (s), 128.6 (d), 127.4 (d), 126.5 (d), 74.8 (t), 69.3 (d), 63.0 (s), 49.4 (s), 44.4 (d), 43.8 (t), 27.3 (t), 26.6 (t), 21.4 (q), 19.8 (q). MS (EI): m/z (%) = 283 (73) [M⁺], 268 (26), 255 (99), 240 (60), 214 (28), 210 (19), 165 (24), 120 (27), 104 (60), 91 (100), 77 (67), 67 (81). HRMS: m/z calcd for C₁₈H₂₁NO₂: 283.1572; found: 283.1571.
A solution of [LiAlH₄˙2THF] complex in toluene (1 M, 1.5 mL, 1.5 mmol) was added dropwise to a solution of keto-oxazoline (0.47 g, 1.67 mmol) in toluene (17 mL) under nitrogen at -40 ˚C. The reaction was stirred until the starting material was consumed (TLC). The reaction mixture was then diluted with EtOAc (150 mL), washed with brine (3 × 10 mL), dried over MgSO₄, concentrated under reduced pressure and the product was purified by flash chromato-graphy eluting with hexane-EtOAc to give 295 mg (62%) of compound 5 and 71 mg (15%) of its C2-epimer. Compound 5: [α]_D ^²5 +14.3 (c = 1.02, CHCl₃). ^¹H NMR (300 MHz, CDCl₃): δ = 7.25 (m, 5 H), 5.53 (br s, 1 H), 5.20 (dd, J = 7.7, 10.1 Hz, 1 H), 4.53 (dd, J = 8.4, 10.2 Hz, 1 H), 4.06 (dd, J = 3.5, 7.8 Hz, 1 H), 4.00 (t, J = 8.1 Hz, 1 H), 2.20 (m, 1 H), 1.83-1.96 (m, 2 H), 1.70-1.80 (m, 2 H), 1.27 (m, 1 H), 1.22 (s, 3 H), 1.14 (m, 1 H), 1.06 (s, 3 H). ^¹³C NMR (75.5 MHz, CDCl3): δ = 170.2 (s), 142.0 (s), 128.5 (d), 127.4 (d), 126.2 (d), 77.5 (d), 73.4 (t), 68.4 (d), 53.0 (s), 49.7 (s), 45.6 (d), 39.3 (t), 30.3 (t), 27.6 (t), 21.9 (q), 20.5 (q). MS (EI) m/z (%) = 285 (10) [M⁺], 270 (71), 257 (100), 242 (88), 216 (22), 202 (50), 174 (16), 151 (24), 120 (25), 104 (46), 91 (73), 77 (57). HRMS: m/z calcd for C₁₈H₂₃NO₂: 285.1729; found: 285.1718.
Experimental Procedure for the Enantioselective HDA Reaction: Copper triflate (9.0 mg, 0.025 mmol) in a Schlenk tube was dried at 90 ºC under vacuum for 1 h. The tube was filled in with nitrogen and ligand 5 (7.1 mg, 0.025 mmol) was added followed by anhyd EtOAc (0.75 mL). The mixture was stirred for 1 h and keto ester 8a (50 mg, 0.25 mmol) dissolved in EtOAc (0.4 mL) was added. After stirring for 30 min, the solution was cooled at 0 ˚C and ethyl vinyl ether (7a; 75 µL, 0.75 mmol) was added. After 3 h, the reaction mixture was filtered through a short pad of silica gel eluting with CH₂Cl₂ to give 61.4 mg (89%) of compound 9aa + 10aa (Table 1, entry 12). HPLC analysis (Chiralpak IC, 2% isopropanol-98% hexane, 1.0 mL/min): (+)-(2S,4R)-9aa: tR = 12.2 min, (-)-(2R,4S)-9aa: tR = 17.0 min, 10aa (enantiomer 1): tR = 27.6 min, 10aa (enantiomer 2): tR = 33.6 min. A pure sample of enantioenriched (+)-9aa was obtained by flash column chromatography, eluting with hexane-CH₂Cl₂ (1:9); [α]_D ^²5 +136 (c = 1.0, CHCl₃, 81% ee). ^¹H NMR (300 MHz, CDCl₃): δ = 7.16-7.29 (m, 5 H), 6.15 (dd, J = 1.8, 2.4 Hz, 1 H), 5.25 (t, J = 2.4 Hz, 1 H), 4.21 (q, J = 7.0 Hz, 2 H), 3.86 (dq, J = 9.9, 7.2 Hz, 1 H), 3.71 (ddd, J = 2.4, 6.3, 11.7 Hz, 1 H), 3.61 (dq, J = 9.9, 7.2 Hz, 1 H), 2.11 (dddd, J = 12.0, 6.3, 2.1, 1.8 Hz, 1 H), 1.76 (ddd, J = 12.0, 11.7, 2.4 Hz, 1 H), 1.25 (t, J = 7.0 Hz, 3 H), 1.18 (t, J = 7.2 Hz, 3 H). ^¹³C NMR (75 MHz, CDCl₃): δ = 162.9 (s), 143.4 (s), 140.8 (s), 128.7 (d), 127.6 (d), 126.8 (d), 115.3 (d), 97.1 (d), 64.2 (t), 61.1 (t), 34.9 (t), 34.0 (d), 15.1 (q), 14.2 (q). MS (EI): m/z (%) = 276 (1.5) [M⁺], 230 (15), 203 (6), 157 (25), 131 (100). HRMS: m/z calcd for C₁₆H₂₀O₄: 276.1362; found: 276.1364. Minor diastereomer 10aa: ^¹H NMR (300 MHz, CDCl₃): δ = 7.21-7.40 (m, 5 H), 6.13 (dd, J = 1.2, 3.0 Hz, 1 H), 5.15 (dd, J = 2.4, 8.1 Hz, 1 H), 4.26 (m, 2 H), 4.03 (dq, J = 9.6, 6.9 Hz, 1 H), 3.71 (ddd, J = 3.0, 6.9, 9.6 Hz, 1 H), 3.63 (dq, J = 9.6, 6.9 Hz, 1 H), 2.30 (dddd, J = 13.5, 6.9, 2.4, 1.2 Hz, 1 H), 1.96 (ddd, J = 13.5, 9.6, 8.1 Hz, 1 H), 1.31 (t, J = 7.2 Hz, 3 H), 1.23 (t, J = 6.9 Hz, 3 H).